Figure 1.

Superficial basal cell carcinomas presenting as erythematous plaques on the left anterior shoulder (labeled A) and the left chest (labeled B) in a man whose metastatic basal cell carcinoma is being treated with a checkpoint inhibitor and is in near complete remission; (a) closer views of the new primary skin cancers on the left anterior shoulder (b) and left chest (c) that developed while the patient’s metastatic basal cell carcinoma was responding to nivolumab. The patient gave signed informed consent for data analysis and the publication of the images.